Practical considerations for treating patients with cancer in the COVID-19 pandemic

Eva Segelov; Craig Underhill; Hans Prenen; Christos Karapetis; Christopher Jackson; Louise Nott; Tim Clay; Nick Pavlakis; Sabe Sabesan; Ellen Heywood; Christopher Steer; Carrie Lethborg; Hui K. Gan; Desmond Yip; Narayan Karanth; Deme Karikios; C. Raina MacIntyre

doi:10.1200/OP.20.00229

Practical considerations for treating patients with cancer in the COVID-19 pandemic

Eva Segelov^*, Craig Underhill, Hans Prenen, Christos Karapetis, Christopher Jackson, Louise Nott, Tim Clay, Nick Pavlakis, Sabe Sabesan, Ellen Heywood, Christopher Steer, Carrie Lethborg, Hui K. Gan, Desmond Yip, Narayan Karanth, Deme Karikios, C. Raina MacIntyre

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

48 Citations (Scopus)

Abstract

Cancer has become a prevalent disease, affecting millions of new patients globally each year. The COVID-19 pandemic is having far-reaching impacts around the world, causing substantial disruptions to health and health care systems that are likely to last for a prolonged period. Early data have suggested that having cancer is a significant risk factor for mortality from severe COVID-19. A diverse group of medical oncologists met to formulate detailed practical advice on systemic anticancer treatments during this crisis. In the context of broad principles, issues including risks of treatment, principles of prioritizing resources, treatment of elderly patients, and psychosocial impact are discussed. Detailed treatment advice and options are given at a tumor stream level. We must maintain care for patients with cancer as best we can and recognize that COVID-19 poses a significant competing risk for death that changes conventional treatment paradigms.

Original language	English
Pages (from-to)	467-482
Number of pages	16
Journal	JCO Oncology Practice
Volume	16
Issue number	8
DOIs	https://doi.org/10.1200/OP.20.00229
Publication status	Published - 2020

Access to Document

10.1200/OP.20.00229

Cite this

Segelov, E., Underhill, C., Prenen, H., Karapetis, C., Jackson, C., Nott, L., Clay, T., Pavlakis, N., Sabesan, S., Heywood, E., Steer, C., Lethborg, C., Gan, H. K., Yip, D., Karanth, N., Karikios, D., & Raina MacIntyre, C. (2020). Practical considerations for treating patients with cancer in the COVID-19 pandemic. JCO Oncology Practice, 16(8), 467-482. https://doi.org/10.1200/OP.20.00229

@article{309cb236c14c482ba8d5cfab3a482ab8,

title = "Practical considerations for treating patients with cancer in the COVID-19 pandemic",

abstract = "Cancer has become a prevalent disease, affecting millions of new patients globally each year. The COVID-19 pandemic is having far-reaching impacts around the world, causing substantial disruptions to health and health care systems that are likely to last for a prolonged period. Early data have suggested that having cancer is a significant risk factor for mortality from severe COVID-19. A diverse group of medical oncologists met to formulate detailed practical advice on systemic anticancer treatments during this crisis. In the context of broad principles, issues including risks of treatment, principles of prioritizing resources, treatment of elderly patients, and psychosocial impact are discussed. Detailed treatment advice and options are given at a tumor stream level. We must maintain care for patients with cancer as best we can and recognize that COVID-19 poses a significant competing risk for death that changes conventional treatment paradigms.",

author = "Eva Segelov and Craig Underhill and Hans Prenen and Christos Karapetis and Christopher Jackson and Louise Nott and Tim Clay and Nick Pavlakis and Sabe Sabesan and Ellen Heywood and Christopher Steer and Carrie Lethborg and Gan, {Hui K.} and Desmond Yip and Narayan Karanth and Deme Karikios and {Raina MacIntyre}, C.",

note = "Publisher Copyright: {\textcopyright} 2020 by American Society of Clinical Oncology.",

year = "2020",

doi = "10.1200/OP.20.00229",

language = "English",

volume = "16",

pages = "467--482",

journal = "JCO Oncology Practice",

issn = "2688-1527",

publisher = "Lippincott Williams and Wilkins Ltd.",

number = "8",

}

Segelov, E, Underhill, C, Prenen, H, Karapetis, C, Jackson, C, Nott, L, Clay, T, Pavlakis, N, Sabesan, S, Heywood, E, Steer, C, Lethborg, C, Gan, HK, Yip, D, Karanth, N, Karikios, D & Raina MacIntyre, C 2020, 'Practical considerations for treating patients with cancer in the COVID-19 pandemic', JCO Oncology Practice, vol. 16, no. 8, pp. 467-482. https://doi.org/10.1200/OP.20.00229

TY - JOUR

T1 - Practical considerations for treating patients with cancer in the COVID-19 pandemic

AU - Segelov, Eva

AU - Underhill, Craig

AU - Prenen, Hans

AU - Karapetis, Christos

AU - Jackson, Christopher

AU - Nott, Louise

AU - Clay, Tim

AU - Pavlakis, Nick

AU - Sabesan, Sabe

AU - Heywood, Ellen

AU - Steer, Christopher

AU - Lethborg, Carrie

AU - Gan, Hui K.

AU - Yip, Desmond

AU - Karanth, Narayan

AU - Karikios, Deme

AU - Raina MacIntyre, C.

PY - 2020

Y1 - 2020

N2 - Cancer has become a prevalent disease, affecting millions of new patients globally each year. The COVID-19 pandemic is having far-reaching impacts around the world, causing substantial disruptions to health and health care systems that are likely to last for a prolonged period. Early data have suggested that having cancer is a significant risk factor for mortality from severe COVID-19. A diverse group of medical oncologists met to formulate detailed practical advice on systemic anticancer treatments during this crisis. In the context of broad principles, issues including risks of treatment, principles of prioritizing resources, treatment of elderly patients, and psychosocial impact are discussed. Detailed treatment advice and options are given at a tumor stream level. We must maintain care for patients with cancer as best we can and recognize that COVID-19 poses a significant competing risk for death that changes conventional treatment paradigms.

AB - Cancer has become a prevalent disease, affecting millions of new patients globally each year. The COVID-19 pandemic is having far-reaching impacts around the world, causing substantial disruptions to health and health care systems that are likely to last for a prolonged period. Early data have suggested that having cancer is a significant risk factor for mortality from severe COVID-19. A diverse group of medical oncologists met to formulate detailed practical advice on systemic anticancer treatments during this crisis. In the context of broad principles, issues including risks of treatment, principles of prioritizing resources, treatment of elderly patients, and psychosocial impact are discussed. Detailed treatment advice and options are given at a tumor stream level. We must maintain care for patients with cancer as best we can and recognize that COVID-19 poses a significant competing risk for death that changes conventional treatment paradigms.

UR - http://www.scopus.com/inward/record.url?scp=85089407056&partnerID=8YFLogxK

U2 - 10.1200/OP.20.00229

DO - 10.1200/OP.20.00229

M3 - Article

SN - 2688-1527

VL - 16

SP - 467

EP - 482

JO - JCO Oncology Practice

JF - JCO Oncology Practice

IS - 8

ER -

Practical considerations for treating patients with cancer in the COVID-19 pandemic

Abstract

Access to Document

Other files and links

Fingerprint

Cite this